Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
British Journal of Cancer
|
May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression
Lingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Journal for Immunotherapy of Cancer
|
May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma
Yawei Ding, Kaifeng Jin, Xiaohe Su, et al.
BMC Cancer
|
January 26, 2026
Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy
Tongzhen Xu, Jinming Shi, Huiying Ma, et al.
BMC Gastroenterology
|
July 28, 2022
Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
Jinming Shi, Ning Li, Yuan Tang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
September 29, 2021
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
Ning Li, Xin Wang, Yuan Tang, et al.
BMC Cancer
|
February 27, 2022
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis
Ning Li, Xiaoyong Xiang, Dongbin Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 7, 2024
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial
Huiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Medicine
|
February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trial
Tongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
British Journal of Cancer
|
May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression
Lingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Journal for Immunotherapy of Cancer
|
May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma
Yawei Ding, Kaifeng Jin, Xiaohe Su, et al.
BMC Cancer
|
January 26, 2026
Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy
Tongzhen Xu, Jinming Shi, Huiying Ma, et al.
BMC Gastroenterology
|
July 28, 2022
Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
Jinming Shi, Ning Li, Yuan Tang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
September 29, 2021
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
Ning Li, Xin Wang, Yuan Tang, et al.
BMC Cancer
|
February 27, 2022
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis
Ning Li, Xiaoyong Xiang, Dongbin Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 7, 2024
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial
Huiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Medicine
|
February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trial
Tongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
Page
of 8